Literature DB >> 15432557

Epibulbar tumors.

J E ASH.   

Abstract

Entities:  

Keywords:  EYE; TUMOR

Mesh:

Year:  1950        PMID: 15432557     DOI: 10.1016/0002-9394(50)90990-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  28 in total

1.  Indeterminate melanocytic proliferations of the conjunctiva.

Authors:  H E Grossniklaus; C E Margo; A R Solomon
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  MALIGNANT MELANOMA OF THE LIMBUS INVOLVING THE WHOLE CORNEA: REPORT OF A CASE.

Authors:  P S REDDY; O M SATYENDRAN
Journal:  Br J Ophthalmol       Date:  1964-11       Impact factor: 4.638

3.  NAEVI AND MELANOMATA OF THE CONJUNCTIVA.

Authors:  B JAY
Journal:  Br J Ophthalmol       Date:  1965-04       Impact factor: 4.638

4.  Dyskeratotic Epibulbar Tumors.

Authors:  A R Irvine
Journal:  Trans Am Ophthalmol Soc       Date:  1963

5.  Current Developments in Ophthalmology.

Authors:  B Jay
Journal:  Proc R Soc Med       Date:  1964-06

6.  [Electron-microscopic findings in Bowen's disease of the conjunctiva (author's transl)].

Authors:  G Koniszewski; H Meythaler
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-11-25

7.  Intraepithelial carcinoma ("Bowen's disease") of the cornea.

Authors:  D Pierse; A D Steele; A Garner; R C Tripathi
Journal:  Br J Ophthalmol       Date:  1971-10       Impact factor: 4.638

8.  Surgical management and histopathology of invasive tumours of the cornea.

Authors:  J Freedman; G Röhm
Journal:  Br J Ophthalmol       Date:  1979-09       Impact factor: 4.638

9.  A prognostic index for patients with malignant melanoma of the conjunctiva.

Authors:  F H Stefani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

10.  Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases.

Authors:  A D Paridaens; D C Minassian; A C McCartney; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.